PPARG and Hepatic fibrosis: In the current study, we provided evidence that treatment with SA ameliorates CCl4-induced liver fibrosis, at least in part by modulating M1/M2 macrophage polarization via activating PPARγ and by inhibiting oxidative stress-induced hepatocyte cell death in mice.